"CHOiCE"! Choose Health: Oncological Patients Cenetered Exercise
CHOiCE
Different Modalities of Exercise for Physical Activity Promotion in Cancer Patients
1 other identifier
interventional
80
1 country
2
Brief Summary
The "CHOICE!" study is an exercise program following the recommendation of the American College of Sports Science for cancer patients. The aims of the intervention are to test the safety and feasibility of a structured program, letting patients choose the modality of delivery. Secondary endpoints include exercise health-related skills and quality of life. The program considers the preferences of exercise of cancer survivors, giving the possibility to choose the exercise modality (autonomous, with a personal trainer or group class). This program will be tested in different cancer populations with different study designs based on different patients cohort (i.e., RCT or single-arm).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2019
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2019
CompletedFirst Submitted
Initial submission to the registry
December 20, 2019
CompletedFirst Posted
Study publicly available on registry
January 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2024
CompletedNovember 14, 2023
November 1, 2023
3.8 years
December 20, 2019
November 13, 2023
Conditions
Outcome Measures
Primary Outcomes (5)
The number of participants with an adverse event
Adverse events will categorize according to the Common Terminology Criteria for Adverse Events (version 5.0)
Change from baseline to 12 weeks
The eligibility rate
The number of patients considered eligible dividing the number of subjects who meet inclusion criteria
At 12 weeks
The recruitment rate
The number of patients randomized dividing the number of subjects considered eligible
At 12 weeks
The adherence to exercise protocol
Measured by the total number of exercise sessions attended
At 12 weeks
The dropouts rate
Defined as a participant who leaves the study for any reason prior to completing the 12-week (24 session) exercise program. All reasons for drop out will be reported.
At 6 months
Secondary Outcomes (10)
Cardiorespiratory fitness
Change from baseline cardiorespiratory fitness at 3 months
Upper limb muscle strength
Change from baseline muscle strength at 3 months
Lower limb muscle strength
Change from baseline muscle strength at 3 months
Upper limb flexibility
Change from baseline flexibility at 3 months
Lower limb flexibility
Change from baseline flexibility at 3 months
- +5 more secondary outcomes
Study Arms (2)
Control
NO INTERVENTIONPhysical exercise
EXPERIMENTALInterventions
The patients can choose between three modality of EX: 1. Autonomous supervised training : a personalized activity is proposed. People choosing this modality have a written material, in which all the exercise, the activity, the frequency, the duration, the intensity are specifically described and reported, to perform the training at home. A training diary and 7 meetings (face to face, or skype or other modality) are proposed for monitoring the intervention. 2. Personal training program: a personalized activity is proposed. Patients are followed individually in a gym contest by a qualified kinesiologist. 3. Group training program: the training is performed in a small group, supervised and monitored by a qualified kinesiologist. The instructor-user ratio is 1:4 - 1:8, depending on the functional conditions and the heterogeneity of the participants.
Eligibility Criteria
You may qualify if:
- a confirmed cancer diagnosis;
- ≥ 8 weeks post-surgical procedure;
- Medical clearance for participation provided by primary care physician or oncologist;
- Informed consent signed;
You may not qualify if:
- Age \< 18 years old;
- Pregnancy;
- Inability to ambulate;
- Contraindication to participation in a regular physical activity program;
- Inability to understand the instructions for PA and/or Mini Mental State index \<24;
- Serious physical limitation and/or Karnofsky index \<50.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Italian League for Fight Cancer
Biella, Turin, 13900, Italy
University of Verona
Verona, 37131, Italy
Related Publications (1)
Avancini A, Borsati A, Baldo E, Ciurnelli C, Trestini I, Tregnago D, Belluomini L, Sposito M, Insolda J, Auriemma A, Fiorio E, Piacentini M, Schena F, Milella M, Pilotto S. A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode. Oncologist. 2024 Jun 3;29(6):e828-e836. doi: 10.1093/oncolo/oyae002.
PMID: 38206849DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Massimo Lanza
Universita di Verona
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
December 20, 2019
First Posted
January 13, 2020
Study Start
September 1, 2019
Primary Completion
June 30, 2023
Study Completion
July 30, 2024
Last Updated
November 14, 2023
Record last verified: 2023-11